FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Deborah Mash

Research Profile

Anatomy

Chemicals & Drugs

Disorders

Procedures

Living Beings

Rats

Physiology

Brain Chemistry

Co-author Network

Publications

TOP 3
Martin A Kohli; Rosalyn Lang; Eden R Martin; Deborah C Mash; Adam Naj; Margaret A Pericak-Vance; Ruchita Rajbhandary; Gary W Small; Patrice Whitehead; Clinton Wright; Gary Beecham; Michael Geoffrey Benatar; Goldie Byrd; Regina M Carney; Elizabeth Crocco; John Gilbert; Harry E Gwirtzman; Jonathan L Haines; Kara Hamilton; Krista John-Williams; Stephan Zuchner
Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians.
Amandeep Mann; Deborah C Mash; Sharon L Miksys; Andrea Gaedigk; Stephen J Kish; Rachel F Tyndale
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
Liyong Wang; Patrice L Whitehead; Stephan Zuchner; Gary Beecham; Paul J Gallins; Jonathan L Haines; Kenju Hara; Chunrong Lu; Eden R Martin; Deborah C Mash; Margaret Pericak-Vance; Justin C Price; Michael Slifer; Jessica M Van Baaren; Gaofeng Wang; John Gilbert
Vitamin D receptor and Alzheimer's disease: a genetic and functional study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Deborah Mash (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Martin A Kohli; Rosalyn Lang; Eden R Martin; Deborah C Mash; Adam Naj; Margaret A Pericak-Vance; Ruchita Rajbhandary; Gary W Small; Patrice Whitehead; Clinton Wright; Gary Beecham; Michael Geoffrey Benatar; Goldie Byrd; Regina M Carney; Elizabeth Crocco; John Gilbert; Harry E Gwirtzman; Jonathan L Haines; Kara Hamilton; Krista John-Williams; Stephan Zuchner
Repeat expansions in the C9ORF72 gene contribute to Alzheimer's disease in Caucasians.
Neurobiology of aging 2013;34(5):1519.e5-12.
2012: Amandeep Mann; Deborah C Mash; Sharon L Miksys; Andrea Gaedigk; Stephen J Kish; Rachel F Tyndale
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients.
Neurobiology of aging 2012;33(9):2160-71.
2012: Liyong Wang; Patrice L Whitehead; Stephan Zuchner; Gary Beecham; Paul J Gallins; Jonathan L Haines; Kenju Hara; Chunrong Lu; Eden R Martin; Deborah C Mash; Margaret Pericak-Vance; Justin C Price; Michael Slifer; Jessica M Van Baaren; Gaofeng Wang; John Gilbert
Vitamin D receptor and Alzheimer's disease: a genetic and functional study.
Neurobiology of aging 2012;33(8):1844.e1-9.
2012: Christian Wider; Zbigniew K Wszolek; Ranjan Duara; Nilufer Erketin-Taner; Matthew J Farrer; Neill R Graff-Radford; Michael G Heckman; Barbara Jasinska-Myga; Deborah C Mash; Kenya Nishioka; Spiridon Papapetropoulos; Rosa Rademakers; Owen A Ross; Hirotake Uchikado; Carles vilarino-guell; Dennis W Dickson
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.
Journal of neurology, neurosurgery, and psychiatry 2012;83(4):424-9.
2012: Jose Gutierrez; Richard Isaacson; Angelica Dawn Marr; Deborah C Mash; Melanie Glenn; Carol K Petito
Thinning of the arterial media layer as a possible preclinical stage in HIV vasculopathy: a pilot study.
Stroke; a journal of cerebral circulation 2012;43(4):1156-8.
2012: Kiyo Mondo; John Pablo; Sandra A Banack; Margaret Basile; Neil Hammerschlag; Deborah C Mash
Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins.
Marine drugs 2012;10(2):509-20.
2012: Qiaoping Yuan; Zhifeng Zhou; Basel Baghal; Maggie Baker; Christina S Barr; Betsy Ferguson; J Dee Higley; Stephen G Lindell; Juan F Lopez; Deborah C Mash; Stephen J Suomi; Robert C Thompson; David Goldman
The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human.
BMC genetics 2012;13():52.
2012: Mary-Anne Enoch; Mitsuru Kimura; Deborah C Mash; Qiaoping Yuan; Zhifeng Zhou; David Goldman
GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats.
PloS one 2012;7(1):e29369.
2011: Adam C Naj; Gyungah Jun; Gary Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew Huentelman; Amanda Myers; M. Michael Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Steven E Arnold; Robert C Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; dennis dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas Galasko; Mary Ganguli; Marla Gearing; Daniel Geschwind; Bernardino Ghetti; John Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C. Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret Pericak-Vance; Lindsay Farrer; Peter St George-Hyslop; Gerard D Schellenberg
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Nature genetics 2011;43(5):436-41.
2011: David S Goldstein; P Sullivan; Courtney Holmes; Irwin J Kopin; M J Basile; Deborah C Mash
Catechols in post-mortem brain of patients with Parkinson disease.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2011;18(5):703-10.
2011: Zhifeng Zhou; Qiaoping Yuan; Deborah C Mash; David Goldman
Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(16):6626-31.
2011: Robert A Moyer; Danxin Wang; Audrey C Papp; Ryan M Smith; Linda Duque; Deborah C Mash; Wolfgang Sadee
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2011;36(4):753-62.
2011: Carles vilarino-guell; A I Soto-Ortolaza; Alex Rajput; Deborah C Mash; Spiridon Papapetropoulos; Rajesh Pahwa; K E Lyons; Ryan Uitti; Zbigniew K Wszolek; dennis dickson; Matthew J Farrer; Owen A Ross
MAPT H1 haplotype is a risk factor for essential tremor and multiple system atrophy.
Neurology 2011;76(7):670-2.
2011: Yvonne Jemimah Edwards; Gary Beecham; William Scott; Sawsan Khuri; Guney Bademci; Demet Tekin; Eden R Martin; Zhijie Jiang; Deborah C Mash; Jarlath ffrench-Mullen; Margaret Pericak-Vance; Nicholas F Tsinoremas; Jeffery Vance
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach.
PloS one 2011;6(2):e16917.
2011: Kenya Nishioka; Owen A Ross; Carles vilarino-guell; Stephanie A Cobb; Jennifer Kachergus; David M A Mann; Julie Snowden; Anna M T Richardson; David Neary; Christopher A Robinson; Alex Rajput; Spiridon Papapetropoulos; Deborah C Mash; Rajesh Pahwa; Kelly E Lyons; Zbigniew K Wszolek; dennis dickson; Matthew J Farrer
Glucocerebrosidase mutations in diffuse Lewy body disease.
Parkinsonism & related disorders 2011;17(1):55-7.
2011: Ryan M Smith; Houda Alachkar; Audrey C Papp; Danxin Wang; Deborah C Mash; Jen-Chyong Wang; Laura J Bierut; Wolfgang Sadee
Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms.
European journal of human genetics : EJHG 2011;19(1):76-83.
2010: Nikhil Adi; Deborah C Mash; Yousuf Ali; Carlos Singer; Lina Shehadeh; Spiridon Papapetropoulos
Melatonin MT1 and MT2 receptor expression in Parkinson's disease.
Medical science monitor : international medical journal of experimental and clinical research 2010;16(2):BR61-7.
2009: Christian Wider; Sarah J Lincoln; Justus C Dachsel; Gregory Kapatos; Michael G Heckman; Nancy N Diehl; Spiridon Papapetropoulos; Deborah C Mash; Alex Rajput; Ali H Rajput; dennis dickson; Zbigniew K Wszolek; Matthew J Farrer
GCH1 expression in human cerebellum from healthy individuals is not gender dependent.
Neuroscience letters 2009;462(1):73-5.
2009: John Pablo; S A Banack; P A Cox; Thomas E Johnson; Spiridon Papapetropoulos; Walter G Bradley; A Buck; Deborah C Mash
Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease.
Acta neurologica Scandinavica 2009;120(4):216-25.
2009: Deborah C Mash; Linda Duque; John Pablo; Yujing Qin; Nikhil Adi; W Lee Hearn; Bruce A Hyma; Steven Karch; Henrik Druid; Charles V Wetli
Brain biomarkers for identifying excited delirium as a cause of sudden death.
Forensic science international 2009;190(1-3):e13-9.
2009: Matthew J Farrer; Lindsey N Williams; Avi A Algom; Jennifer Kachergus; Mary Hulihan; Owen A Ross; Alex Rajput; Spiridon Papapetropoulos; Deborah C Mash; dennis dickson
Glucosidase-beta variations and Lewy body disorders.
Parkinsonism & related disorders 2009;15(6):414-6.
2009: Carles vilarino-guell; Alexandra I Soto; Sarah J Lincoln; Samia Ben Yahmed; Mounir Kefi; Michael G Heckman; Mary Hulihan; Hua Chai; Nancy N Diehl; Rim Amouri; Alex Rajput; Deborah C Mash; dennis dickson; Lefkos T Middleton; Rachel A Gibson; Faycal Hentati; Matthew J Farrer
ATP13A2 variability in Parkinson disease.
Human mutation 2009;30(3):406-10.
2009: Christian Wider; Justus C Dachsel; Alexandra I Soto; Michael G Heckman; Nancy N Diehl; Mei Yue; Sarah J Lincoln; Jan Aasly; Kristoffer Haugarvoll; John Q Trojanowski; Spiridon Papapetropoulos; Deborah C Mash; Alex Rajput; Ali H Rajput; J Mark Gibson; Timothy Lynch; dennis dickson; Ryan Uitti; Zbigniew K Wszolek; Matthew J Farrer; Owen A Ross
FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
Movement disorders : official journal of the Movement Disorder Society 2009;24(3):455-9.
2009: Walter G Bradley; Deborah C Mash
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 2009;10 Suppl 2():7-20.
2009: Xueying Jiang; Jian Zhou; Deborah C Mash; Ann M Marini; Robert Henry Lipsky
Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution.
Neuromolecular medicine 2009;11(1):1-12.
2008: Amandeep Mann; Sharon Miksys; Anna Lee; Deborah C Mash; Rachel F Tyndale
Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.
Neuropharmacology 2008;55(7):1147-55.
2008: Melinda E Lull; Willard M Freeman; Kent Vrana; Deborah C Mash
Correlating human and animal studies of cocaine abuse and gene expression.
Annals of the New York Academy of Sciences 2008;1141():58-75.
2008: Zhifeng Zhou; Guanshan Zhu; Ahmad R Hariri; Mary-Anne Enoch; David Scott; Rajita Sinha; Matti Virkkunen; Deborah C Mash; Robert Henry Lipsky; Xian-Zhang Hu; Colin A Hodgkinson; Ke Xu; Beata Buzas; Qiaoping Yuan; Pei-Hong Shen; Robert E Ferrell; Stephen B Manuck; Sarah M Brown; Richard L Hauger; Christian S Stohler; Jon K Zubieta; David Goldman
Genetic variation in human NPY expression affects stress response and emotion.
Nature 2008;452(7190):997-1001.
2008: Deborah C Mash; Nikhil Adi; Linda Duque; John Pablo; Mahendra Kumar; Frank R Ervin
Alpha synuclein protein levels are increased in serum from recently abstinent cocaine abusers.
Drug and alcohol dependence 2008;94(1-3):246-50.
2007: Susan Schenk; Lincoln Hely; Barbara Lake; Evangeline Daniela; David Gittings; Deborah C Mash
MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding.
The European journal of neuroscience 2007;26(11):3229-36.
2007: Sarah J Lincoln; Owen A Ross; Nicole M Milkovic; dennis dickson; Alex Rajput; Christopher A Robinson; Spiridon Papapetropoulos; Deborah C Mash; Matthew J Farrer
Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy.
Parkinsonism & related disorders 2007;13(6):340-2.
2007: Spiridon Papapetropoulos; Deborah C Mash
Insular pathology in Parkinson's disease patients with orthostatic hypotension.
Parkinsonism & related disorders 2007;13(5):308-11.
2007: Timothy G Lesnick; Spiridon Papapetropoulos; Deborah C Mash; Jarlath ffrench-Mullen; Lina Shehadeh; Mariza de Andrade; John R Henley; Walter A Rocca; J Eric Ahlskog; Demetrius M Maraganore
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.
PLoS genetics 2007;3(6):e98.
2007: Spiridon Papapetropoulos; Nikhil Adi; Deborah C Mash; Lina Shehadeh; Nanette H Bishopric; Lina Shehadeh
Expression of alpha-synuclein mRNA in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(7):1057-9; author reply 1057.
2007: Spiridon Papapetropoulos; Alexander Tuchman; Daniel Laufer; Deborah C Mash
Hallucinations in multiple system atrophy.
Parkinsonism & related disorders 2007;13(3):193-4.
2007: Spiridon Papapetropoulos; Matthew J Farrer; Jeremy T Stone; Nicole M Milkovic; Owen A Ross; Linda Calvo; Donald McQuorquodale; Deborah C Mash
Phenotypic associations of tau and ApoE in Parkinson's disease.
Neuroscience letters 2007;414(2):141-4.
2007: Spiridon Papapetropoulos; Alexander Tuchman; Daniel Laufer; Athanassios G Papatsoris; Nektarios Papapetropoulos; Deborah C Mash
Causes of death in multiple system atrophy.
Journal of neurology, neurosurgery, and psychiatry 2007;78(3):327-9.
2007: Spiridon Papapetropoulos; Deborah C Mash
Motor fluctuations and dyskinesias in advanced/end stage Parkinson's disease: a study from a population of brain donors.
Journal of neural transmission (Vienna, Austria : 1996) 2007;114(3):341-5.
2007: Aneta Grudzien; Pamela Shaw; Sandra Weintraub; Eileen H Bigio; Deborah C Mash; Marek-Marsel Mesulam
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease.
Neurobiology of aging 2007;28(3):327-35.
2007: Spiridon Papapetropoulos; Margaret Basel; Deborah C Mash
Dopaminergic innervation of the human striatum in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2007;22(2):286-8.
2007: Deborah C Mash; Jarlath ffrench-Mullen; Nikhil Adi; Yujing Qin; Andrew Buck; John Pablo
Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling.
PloS one 2007;2(11):e1187.
2007: Nilesh S Tannu; Deborah C Mash; Scott Hemby
Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims.
Molecular psychiatry 2007;12(1):55-73.
2006: Spiridon Papapetropoulos; Jose M Villar; Jocely Gonzalez; Deborah C Mash
Disparities in death certificates of Parkinson's disease patients: a report from a population of brain donors.
Movement disorders : official journal of the Movement Disorder Society 2006;21(10):1791-2; author reply 1792.
2006: Spiridon Papapetropoulos; Carlos Singer; Owen A Ross; Mathias Toft; Joseph L Johnson; Matthew J Farrer; Deborah C Mash
Clinical heterogeneity of the LRRK2 G2019S mutation.
Archives of neurology 2006;63(9):1242-6.
2006: Daniele Passarella; A Barilli; S M N Efange; Elaine Elisabetsky; Mirna Bainy Leal; Giordano Lesma; V M Linck; Deborah C Mash; M Martinelli; I Peretto; Alessandra Silvani; Bruno Danieli
Nature-inspired indolyl-2-azabicyclo[2.2.2]oct-7-ene derivatives as promising agents for the attenuation of withdrawal symptoms: synthesis of 20-desethyl-20-hydroxymethyl-11-demethoxyibogaine.
Natural product research 2006;20(8):758-65.
2006: Tomas Drgon; Zhicheng Lin; Gene-Jack Wang; Joanna S Fowler; John Pablo; Deborah C Mash; Nora D Volkow; George R. Uhl
Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo.
Cellular and molecular neurobiology 2006;26(4-6):875-89.
2006: Spiridon Papapetropoulos; J M Villar; Deborah C Mash
Is ischemic cerebrovascular disease a risk factor for dementia in patients with Parkinson's disease?
Acta neurologica Scandinavica 2006;113(5):353-4.
2006: Spiridon Papapetropoulos; Donald McCorquodale; Jocely Gonzalez; Lucie Jean-Gilles; Deborah C Mash
Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.
Parkinsonism & related disorders 2006;12(4):253-6.
2006: Owen A Ross; Mathias Toft; Andrew J Whittle; Joseph L Johnson; Spiridon Papapetropoulos; Deborah C Mash; Irene Litvan; Mark F Gordon; Zbigniew K Wszolek; Matthew J Farrer; dennis dickson
Lrrk2 and Lewy body disease.
Annals of neurology 2006;59(2):388-93.
2006: Spiridon Papapetropoulos; Jarlath ffrench-Mullen; Donald McCorquodale; Yujing Qin; John Pablo; Deborah C Mash
Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease.
Gene expression 2006;13(3):205-15.
2006: Spiridon Papapetropoulos; Abraham Lieberman; Jocely Gonzalez; Carlos Singer; Daniel Z Laufer; Deborah C Mash
Family history of dementia: dementia with lewy bodies and dementia in Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2006;18(1):113-6.
2006: Spiridon Papapetropoulos; J Gonzalez; Deborah C Mash
The effect of ischemic cerebrovascular disease on the clinical characteristics of Parkinson's disease. A post-mortem study.
European journal of neurology : the official journal of the European Federation of Neurological Societies 2006;13(1):96-7.
2005: Scott Hemby; Wenxue Tang; E Chris Muly; Michael J Kuhar; Leonard L Howell; Deborah C Mash
Cocaine-induced alterations in nucleus accumbens ionotropic glutamate receptor subunits in human and non-human primates.
Journal of neurochemistry 2005;95(6):1785-93.
2005: Spiridon Papapetropoulos; Carlos Singer; Donald McCorquodale; Jocely Gonzalez; Deborah C Mash
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP).
Parkinsonism & related disorders 2005;11(7):459-63.
2005: Yujing Qin; Qinjie Ouyang; John Pablo; Deborah C Mash
Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum.
Neuroreport 2005;16(13):1489-93.
2005: Spiridon Papapetropoulos; Deborah C Mash
Psychotic symptoms in Parkinson's disease. From description to etiology.
Journal of neurology 2005;252(7):753-64.
2005: Spiridon Papapetropoulos; A Lieberman; J Gonzalez; Deborah C Mash
Can Alzheimer's type pathology influence the clinical phenotype of Parkinson's disease?
Acta neurologica Scandinavica 2005;111(6):353-9.
2005: Spiridon Papapetropoulos; J Gonzalez; A Lieberman; J M Villar; Deborah C Mash
Dementia in Parkinson's disease: a post-mortem study in a population of brain donors.
International journal of geriatric psychiatry 2005;20(5):418-22.
2005: Spiridon Papapetropoulos; Carlos Singer; Jose M Villar; Jocely Gonzalez; Deborah C Mash
Does cigarette smoking provide clinically significant neuroprotection among patients diagnosed with Parkinson's disease?
Movement disorders : official journal of the Movement Disorder Society 2005;20(5):641-2.
2005: Deborah C Mash; Qinjie Ouyang; Yujing Qin; John Pablo
Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers.
Journal of neuroscience methods 2005;143(1):79-85.
2005: Spiridon Papapetropoulos; Deborah C Mash
Alpha-synuclein aggregation and its relation to neurodegenerative diseases.
Annals of neurology 2005;57(4):605; author reply 605-6.
2005: Spiridon Papapetropoulos; Deborah C Mash
The neurochemical mechanism of rebound psychosis in Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 2005;20(4):515; author reply 515.
2005: Spiridon Papapetropoulos; Deborah C Mash
Visual hallucinations in progressive supranuclear palsy.
European neurology 2005;54(4):217-9.
2005: Spiridon Papapetropoulos; Jocely Gonzalez; Deborah C Mash
Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors.
European neurology 2005;54(1):1-9.
2005: M A Rossi; Deborah C Mash; Leyla deToledo-Morrell
Spatial memory in aged rats is related to PKCgamma-dependent G-protein coupling of the M1 receptor.
Neurobiology of aging 2005;26(1):53-68.
2004: Guanshan Zhu; Robert Henry Lipsky; Ke Xu; Sameer Ali; Thomas Hyde; Joel Kleinman; Longina A Akhtar; Deborah C Mash; David Goldman
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assay.
Psychopharmacology 2004;177(1-2):178-84.
2004: Marek-Marsel Mesulam; Pamela Shaw; Deborah C Mash; Sandra Weintraub
Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum.
Annals of neurology 2004;55(6):815-28.
2004: Boyd G Stephens; Jeffrey M Jentzen; Steven Karch; Charles V Wetli; Deborah C Mash
National Association of Medical Examiners position paper on the certification of cocaine-related deaths.
The American journal of forensic medicine and pathology 2004;25(1):11-3.
2004: Boyd G Stephens; Jeffrey M Jentzen; Steven Karch; Deborah C Mash; Charles V Wetli
Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death.
The American journal of forensic medicine and pathology 2004;25(1):1-10.
2004: Paul J Lockhart; Sarah J Lincoln; Mary Hulihan; Jennifer Kachergus; Kristen Wilkes; Gina Bisceglio; Deborah C Mash; Matthew J Farrer
DJ-1 mutations are a rare cause of recessively inherited early onset parkinsonism mediated by loss of protein function.
Journal of medical genetics 2004;41(3):e22.
2003: Michael J Hurley; Deborah C Mash; Peter Jenner
Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain.
Journal of neural transmission (Vienna, Austria : 1996) 2003;110(11):1279-88.
2003: Michael J Hurley; Deborah C Mash; Peter Jenner
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR.
The European journal of neuroscience 2003;18(9):2668-72.
2003: Sharon Miksys; Caryn Lerman; Peter G Shields; Deborah C Mash; Rachel F Tyndale
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain.
Neuropharmacology 2003;45(1):122-32.
2003: Angela L Guillozet; Sandra Weintraub; Deborah C Mash; Marek-Marsel Mesulam
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment.
Archives of neurology 2003;60(5):729-36.
2003: Wen-Xue Tang; Wendy H Fasulo; Deborah C Mash; Scott Hemby
Molecular profiling of midbrain dopamine regions in cocaine overdose victims.
Journal of neurochemistry 2003;85(4):911-24.
2003: Lisa A Howard; Sharon Miksys; Ewa Hoffmann; Deborah C Mash; Rachel F Tyndale
Brain CYP2E1 is induced by nicotine and ethanol in rat and is higher in smokers and alcoholics.
British journal of pharmacology 2003;138(7):1376-86.
2003: Deborah C Mash; Qinjie Ouyang; John Pablo; Margaret Basile; Sari Izenwasser; Abraham Lieberman; Richard J Perrin
Cocaine abusers have an overexpression of alpha-synuclein in dopamine neurons.
The Journal of neuroscience : the official journal of the Society for Neuroscience 2003;23(7):2564-71.
2003: Daniele Passarella; Raffaele Favia; Alessandra Giardini; Giordano Lesma; Marisa Martinelli; Alessandra Silvani; Bruno Danieli; S M N Efange; Deborah C Mash
Ibogaine analogues. Synthesis and preliminary pharmacological evaluation of 7-heteroaryl-2-azabicyclo[2.2.2]oct-7-enes.
Bioorganic & medicinal chemistry 2003;11(6):1007-14.
2002: Rogene F Henderson; Edward B Barr; Walter B Blackwell; Connie R Clark; Carole A Conn; Roma Kalra; Thomas H March; Mohan L Sopori; Stephanie Holmgren; Margaret G Ménache; Deborah C Mash
Response of rats to low levels of sarin.
Toxicology and applied pharmacology 2002;184(2):67-76.
2002: Sharon Miksys; Yushu Rao; Ewa Hoffmann; Deborah C Mash; Rachel F Tyndale
Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics.
Journal of neurochemistry 2002;82(6):1376-87.
2002: Sylvia Pérez; Margret Basile; Deborah C Mash; Elliott J Mufson
Galanin receptor over-expression within the amygdala in early Alzheimer's disease: an in vitro autoradiographic analysis.
Journal of chemical neuroanatomy 2002;24(2):109-16.
2002: Michael J Bannon; Barb Pruetz; Amy B Manning-Bog; Christopher J Whitty; Sharon Kay Michelhaugh; Paola Sacchetti; James G Granneman; Deborah C Mash; Carl J Schmidt
Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(9):6382-5.
2002: Deborah C Mash; John Pablo; Qinjie Ouyang; W Lee Hearn; Sari Izenwasser
Dopamine transport function is elevated in cocaine users.
Journal of neurochemistry 2002;81(2):292-300.
2001: Rogene F Henderson; Edward B Barr; Walter B Blackwell; C R Clark; Carole A Conn; Roma Kalra; Thomas H March; Mohan L Sopori; Stephanie Holmgren; Margaret G Ménache; Deborah C Mash; Karol Dokladny; Wieslaw Kozak; Anna Kozak; Maceij Wachulec; Karin Rudolph; Matthew J Kluger; Shashi P Singh; Seddigheh Razani-Boroujerdi; Raymond J Langley
Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illness.
Toxicology and industrial health 2001;17(5-10):294-7.
2001: Michael H Baumann; Richard B Rothman; John Pablo; Deborah C Mash
In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats.
The Journal of pharmacology and experimental therapeutics 2001;297(2):531-9.
2001: Michael J Hurley; Deborah C Mash; Peter Jenner
Dopamine D(1) receptor expression in human basal ganglia and changes in Parkinson's disease.
Brain research. Molecular brain research 2001;87(2):271-9.
2001: Amy J Eshleman; K Wolfrum; Deborah C Mash; K Christensen; Aaron Janowsky
Drug interactions with the dopamine transporter in cryopreserved human caudate.
The Journal of pharmacology and experimental therapeutics 2001;296(2):442-9.
2001: Scott E Counts; Sylvia E Perez; U Kahl; T Bartfai; R P Bowser; Darlene C Deecher; Deborah C Mash; Jacqueline N Crawley; Elliott J Mufson
Galanin: neurobiologic mechanisms and therapeutic potential for Alzheimer's disease.
CNS drug reviews 2001;7(4):445-70.
2001: Michael H Baumann; John Pablo; Syed F Ali; Richard B Rothman; Deborah C Mash
Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine.
The Alkaloids. Chemistry and biology 2001;56():79-113.
2001: Deborah C Mash; CA Kovera; John Pablo; R Tyndale; F R Ervin; J D Kamlet; W Lee Hearn
Ibogaine in the treatment of heroin withdrawal.
The Alkaloids. Chemistry and biology 2001;56():155-71.
2000: Deborah C Mash; J K Staley; Sari Izenwasser; M Basile; A James Ruttenber
Serotonin transporters upregulate with chronic cocaine use.
Journal of chemical neuroanatomy 2000;20(3-4):271-80.
2000: Y Wang; E TesFaye; Robert P Yasuda; Deborah C Mash; David M Armstrong; Barry B Wolfe
Effects of post-mortem delay on subunits of ionotropic glutamate receptors in human brain.
Brain research. Molecular brain research 2000;80(2):123-31.
2000: Michael J Hurley; Deborah C Mash; Peter Jenner
Adenosine A(2A) receptor mRNA expression in Parkinson's disease.
Neuroscience letters 2000;291(1):54-8.
2000: Deborah C Mash; CA Kovera; John Pablo; R F Tyndale; F D Ervin; I C Williams; E G Singleton; M Mayor
Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.
Annals of the New York Academy of Sciences 2000;914():394-401.
2000: Michael H Baumann; John Pablo; Syed F Ali; Richard B Rothman; Deborah C Mash
Noribogaine (12-hydroxyibogamine): a biologically active metabolite of the antiaddictive drug ibogaine.
Annals of the New York Academy of Sciences 2000;914():354-68.
2000: Elliott J Mufson; Darlene C Deecher; M Basile; S Izenwasse; Deborah C Mash
Galanin receptor plasticity within the nucleus basalis in early and late Alzheimer's disease: an in vitro autoradiographic analysis.
Neuropharmacology 2000;39(8):1404-12.
1999: L Chen; DM Segal; Carlos T Moraes; Deborah C Mash
Dopamine transporter mRNA in autopsy studies of chronic cocaine users.
Brain research. Molecular brain research 1999;73(1-2):181-5.
1999: L Chen; DM Segal; Deborah C Mash
Semi-quantitative reverse-transcriptase polymerase chain reaction: an approach for the measurement of target gene expression in human brain.
Brain research. Brain research protocols 1999;4(2):132-9.
1999: C Zubaran; Mohammed Shoaib; Ian P Stolerman; John Pablo; Deborah C Mash
Noribogaine generalization to the ibogaine stimulus: correlation with noribogaine concentration in rat brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 1999;21(1):119-26.
1999: J L Haracz; Deborah C Mash; Ratna Sircar
A multicomponent learning model of drug abuse. Drug taking and craving may involve separate brain circuits underlying instrumental and classical conditioning, respectively.
Annals of the New York Academy of Sciences 1999;877():811-9.
1999: Deborah C Mash; J K Staley
D3 dopamine and kappa opioid receptor alterations in human brain of cocaine-overdose victims.
Annals of the New York Academy of Sciences 1999;877():507-22.
1999: Brian Ciliax; G W Drash; J K Staley; S Haber; C J Mobley; Gary Miller; Elliott J Mufson; Deborah C Mash; Allan Levey
Immunocytochemical localization of the dopamine transporter in human brain.
The Journal of comparative neurology 1999;409(1):38-56.
1999: Shuang Y Ma; Brian Ciliax; Glenn T Stebbins; Syed Jaffar; Jeffrey N. Joyce; Elizabeth J Cochran; Jeffrey Kordower; Deborah C Mash; Allan Levey; Elliott J Mufson
Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra.
The Journal of comparative neurology 1999;409(1):25-37.
1999: James Callaway; D J McKenna; Charles S Grob; G S Brito; LP Raymon; Russell Poland; E N Andrade; E O Andrade; Deborah C Mash
Pharmacokinetics of Hoasca alkaloids in healthy humans.
Journal of ethnopharmacology 1999;65(3):243-56.
1999: Gary Miller; Jeffrey D Erickson; J T Perez; S N Penland; Deborah C Mash; David B Rye; Allan Levey
Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.
Experimental neurology 1999;156(1):138-48.
1999: Sari Izenwasser; J K Staley; S Cohn; Deborah C Mash
Characterization of kappa1-opioid receptor binding in human insular cortex.
Life sciences 1999;65(9):857-62.
1998: Elliott J Mufson; U Kahl; R Bowser; Deborah C Mash; Jeffrey Kordower; Darlene C Deecher
Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential.
Annals of the New York Academy of Sciences 1998;863():291-304.
1998: Gillian Einstein; V Patel; P Bautista; M Kenna; L Melone; R Fader; K Karson; S Mann; Ann M Saunders; Christine M Hulette; Deborah C Mash; Allen D Roses; Donald E Schmechel
Intraneuronal ApoE in human visual cortical areas reflects the staging of Alzheimer disease pathology.
Journal of neuropathology and experimental neurology 1998;57(12):1190-201.
1998: Christine M Hulette; Kathleen A Welsh-Bohmer; M G Murray; Ann M Saunders; Deborah C Mash; Lauren M McIntyre
Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.
Journal of neuropathology and experimental neurology 1998;57(12):1168-74.
1998: S M N Efange; Deborah C Mash; AB Khare; Q Ouyang
Modified ibogaine fragments: synthesis and preliminary pharmacological characterization of 3-ethyl-5-phenyl-1,2,3,4,5, 6-hexahydroazepino[4,5-b]benzothiophenes.
Journal of medicinal chemistry 1998;41(23):4486-91.
1998: R S Obach; John Pablo; Deborah C Mash
Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine.
Drug metabolism and disposition: the biological fate of chemicals 1998;26(8):764-8.
1998: Deborah C Mash; CA Kovera; Billy E Buck; Michael D Norenberg; P Shapshak; W Lee Hearn; J Sanchez-Ramos
Medication development of ibogaine as a pharmacotherapy for drug dependence.
Annals of the New York Academy of Sciences 1998;844():274-92.
1998: Darlene C Deecher; Deborah C Mash; J K Staley; Elliott J Mufson
Characterization and localization of galanin receptors in human entorhinal cortex.
Regulatory peptides 1998;73(3):149-59.
1998: John Pablo; Deborah C Mash
Noribogaine stimulates naloxone-sensitive [35S]GTPgammaS binding.
Neuroreport 1998;9(1):109-14.
1997: Angela L Guillozet; J F Smiley; Deborah C Mash; Marek-Marsel Mesulam
Butyrylcholinesterase in the life cycle of amyloid plaques.
Annals of neurology 1997;42(6):909-18.
1997: J K Staley; Deborah C Mash; SM Parsons; AB Khare; S M N Efange
Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
European journal of pharmacology 1997;338(2):159-69.
1997: J K Staley; R B Rothman; K C Rice; J Partilla; Deborah C Mash
Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1997;17(21):8225-33.
1997: S M N Efange; E M Garland; J K Staley; AB Khare; Deborah C Mash
Vesicular acetylcholine transporter density and Alzheimer's disease.
Neurobiology of aging 1997;18(4):407-13.
1997: DM Segal; Carlos T Moraes; Deborah C Mash
Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.
Brain research. Molecular brain research 1997;45(2):335-9.
1997: Gary Miller; J K Staley; Craig J Heilman; J T Perez; Deborah C Mash; David B Rye; Allan Levey
Immunochemical analysis of dopamine transporter protein in Parkinson's disease.
Annals of neurology 1997;41(4):530-9.
1997: J K Staley; J Z Talbot; Brian Ciliax; Gary Miller; Allan Levey; M P Kung; H F Kung; Deborah C Mash
Radioligand binding and immunoautoradiographic evidence for a lack of toxicity to dopaminergic nerve terminals in human cocaine overdose victims.
Brain research 1997;747(2):219-29.
1997: Deborah C Mash
Are neuroadaptations in D3 dopamine receptors linked to the development of cocaine dependence?
Molecular psychiatry 1997;2(1):7-8.
1997: Deborah C Mash
D3 receptor binding in human brain during cocaine overdose.
Molecular psychiatry 1997;2(1):5-6.
1997: A James Ruttenber; J Lawler-Heavner; M Yin; Charles V Wetli; W Lee Hearn; Deborah C Mash
Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity.
Journal of forensic sciences 1997;42(1):25-31.
1996: James Callaway; LP Raymon; W L Hearn; D J McKenna; Charles S Grob; G S Brito; Deborah C Mash
Quantitation of N,N-dimethyltryptamine and harmala alkaloids in human plasma after oral dosing with ayahuasca.
Journal of analytical toxicology 1996;20(6):492-7.
1996: J K Staley; Deborah C Mash
Adaptive increase in D3 dopamine receptors in the brain reward circuits of human cocaine fatalities.
The Journal of neuroscience : the official journal of the Society for Neuroscience 1996;16(19):6100-6.
1996: J K Staley; Q Ouyang; John Pablo; W L Hearn; D D Flynn; R B Rothman; K C Rice; Deborah C Mash
Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.
Psychopharmacology 1996;127(1):10-8.
1996: C V Wetli; Deborah C Mash; S B Karch
Cocaine-associated agitated delirium and the neuroleptic malignant syndrome.
The American journal of emergency medicine 1996;14(4):425-8.
1996: S M Shah; Paul Shapshak; J E Rivers; R V Stewart; NL Weatherby; Ke-Qin Xin; J Bryan Page; DALE D CHITWOD; Deborah C Mash; David Vlahov; Clyde B McCoy
Detection of HIV-1 DNA in needle/syringes, paraphernalia, and washes from shooting galleries in Miami: a preliminary laboratory report.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(3):301-6.
1996: Deborah C Mash; J K Staley; F M Doepel; Simon N Young; F R Ervin; Roberta Palmour
Altered dopamine transporter densities in alcohol-preferring vervet monkeys.
Neuroreport 1996;7(2):457-62.
1995: J K Staley; J W Boja; Frank carroll; Herbert H Seltzman; C D Wyrick; Anita H Lewin; Philip Abraham; Deborah C Mash
Mapping dopamine transporters in the human brain with novel selective cocaine analog [125I]RTI-121.
Synapse (New York, N.Y.) 1995;21(4):364-72.
1995: Michael H Baumann; Deborah C Mash; J K Staley
The serotonin agonist m-chlorophenylpiperazine (mCPP) binds to serotonin transporter sites in human brain.
Neuroreport 1995;6(16):2150-2.
1995: W L Hearn; John Pablo; G W Hime; Deborah C Mash
Identification and quantitation of ibogaine and an o-demethylated metabolite in brain and biological fluids using gas chromatography-mass spectrometry.
Journal of analytical toxicology 1995;19(6):427-34.
1995: Deborah C Mash; J K Staley; John Pablo; Alice M Holohean; John C Hackman; Robert A Davidoff
Properties of ibogaine and its principal metabolite (12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.
Neuroscience letters 1995;192(1):53-6.
1995: D D Flynn; G Ferrari-DiLeo; Deborah C Mash; Allan Levey
Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease.
Journal of neurochemistry 1995;64(4):1888-91.
1995: D D Flynn; G Ferrari-DiLeo; Allan Levey; Deborah C Mash
Differential alterations in muscarinic receptor subtypes in Alzheimer's disease: implications for cholinergic-based therapies.
Life sciences 1995;56(11-12):869-76.
1995: G Ferrari-DiLeo; Deborah C Mash; D D Flynn
Attenuation of muscarinic receptor-G-protein interaction in Alzheimer disease.
Molecular and chemical neuropathology / sponsored by the International Society for Neurochemistry and the World Federation of Neurology and research groups on neurochemistry and cerebrospinal fluid 1995;24(1):69-91.
1995: Deborah C Mash; J K Staley; Michael H Baumann; R B Rothman; W L Hearn
Identification of a primary metabolite of ibogaine that targets serotonin transporters and elevates serotonin.
Life sciences 1995;57(3):PL45-50.
1994: J K Staley; W L Hearn; A James Ruttenber; Charles V Wetli; Deborah C Mash
High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims.
The Journal of pharmacology and experimental therapeutics 1994;271(3):1678-85.
1994: G Ferrari-Dileo; M Waelbroeck; Deborah C Mash; D D Flynn
Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
Molecular pharmacology 1994;46(6):1028-35.
1994: Simon Chakko; S Sepulveda; K M Kessler; M C Sotomayor; Deborah C Mash; R J Prineas; Robert J Myerburg
Frequency and type of electrocardiographic abnormalities in cocaine abusers (electrocardiogram in cocaine abuse).
The American journal of cardiology 1994;74(7):710-3.
1994: Helen A Baghdoyan; V J Mallios; R B Duckrow; Deborah C Mash
Localization of muscarinic receptor subtypes in brain stem areas regulating sleep.
Neuroreport 1994;5(13):1631-4.
1994: Paul Shapshak; Clyde B McCoy; S M Shah; J Bryan Page; J E Rivers; NL Weatherby; DALE D CHITWOD; Deborah C Mash
Preliminary laboratory studies of inactivation of HIV-1 in needles and syringes containing infected blood using undiluted household bleach.
Journal of acquired immune deficiency syndromes 1994;7(7):754-9.
1994: George R. Uhl; D Walther; Deborah C Mash; B Faucheux; France Javoy-Agid
Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
Annals of neurology 1994;35(4):494-8.
1994: J K Staley; M Basile; D D Flynn; Deborah C Mash
Visualizing dopamine and serotonin transporters in the human brain with the potent cocaine analogue [125I]RTI-55: in vitro binding and autoradiographic characterization.
Journal of neurochemistry 1994;62(2):549-56.
1994: Cyrus Zabetian; J K Staley; D D Flynn; Deborah C Mash
[3H]-(+)-pentazocine binding to sigma recognition sites in human cerebellum.
Life sciences 1994;55(20):PL389-95.
1993: M Emre; Stephan Heckers; Deborah C Mash; Changiz Geula; Marek-Marsel Mesulam
Cholinergic innervation of the amygdaloid complex in the human brain and its alterations in old age and Alzheimer's disease.
The Journal of comparative neurology 1993;336(1):117-34.
1993: D D Flynn; Deborah C Mash
Distinct kinetic binding properties of N-[3H]-methylscopolamine afford differential labeling and localization of M1, M2, and M3 muscarinic receptor subtypes in primate brain.
Synapse (New York, N.Y.) 1993;14(4):283-96.
1993: Paul Shapshak; Clyde B McCoy; J E Rivers; DALE D CHITWOD; Deborah C Mash; NL Weatherby; James A Inciardi; S M Shah; B S Brown
Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach.
Journal of acquired immune deficiency syndromes 1993;6(2):218-9.
1993: Deborah C Mash; J Sanchez-Ramos; William J Weiner
Transferrin receptor regulation in Parkinson's disease and MPTP-treated mice.
Advances in neurology 1993;60():133-9.
1992: Deborah C Mash; Cyrus Zabetian
Sigma receptors are associated with cortical limbic areas in the primate brain.
Synapse (New York, N.Y.) 1992;12(3):195-205.
1992: S Z Wang; S Z Zhu; Deborah C Mash; Esam E El-Fakahany
Comparison of the concentration of messenger RNA encoding four muscarinic receptor subtypes in control and Alzheimer brains.
Brain research. Molecular brain research 1992;16(1-2):64-70.
1992: Marek-Marsel Mesulam; Deborah C Mash; Louis B Hersh; Mark Bothwell; Changiz Geula
Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus.
The Journal of comparative neurology 1992;323(2):252-68.
1992: J R Sanchez-Ramos; S Song; J Oppenheimer; Deborah C Mash; William J Weiner
Analysis of the protective effects of 21-aminosteroids in MPP(+)-induced neurotoxicity to dopaminergic neurons in mesencephalic cultures.
Annals of the New York Academy of Sciences 1992;648():338-9.
1992: Marek-Marsel Mesulam; Louis B Hersh; Deborah C Mash; Changiz Geula
Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study.
The Journal of comparative neurology 1992;318(3):316-28.
1992: D D Flynn; A A Vaishnav; Deborah C Mash
Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors.
Molecular pharmacology 1992;41(4):736-42.
1992: Miguel Perez; Myron Rosenthal; Thomas J Sick; P L Lutz; John Pablo; Deborah C Mash
Downregulation of sodium channels during anoxia: a putative survival strategy of turtle brain.
The American journal of physiology 1992;262(4 Pt 2):R712-5.
1992: J R Sanchez-Ramos; S Song; Deborah C Mash; William J Weiner
21-aminosteroids interact with the dopamine transporter to protect against 1-methyl-4-phenylpyridinium-induced neurotoxicity.
Journal of neurochemistry 1992;58(1):328-34.
1991: Deborah C Mash; John Pablo; Billy E Buck; J Sanchez-Ramos; William J Weiner
Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice.
Experimental neurology 1991;114(1):73-81.
1991: W L Hearn; S Rose; J Wagner; A Ciarleglio; Deborah C Mash
Cocaethylene is more potent than cocaine in mediating lethality.
Pharmacology, biochemistry, and behavior 1991;39(2):531-3.
1991: D D Flynn; D A Weinstein; Deborah C Mash
Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
Annals of neurology 1991;29(3):256-62.
1991: Yossef Itzhak; Deborah C Mash; S H Zhang; I Stein
Characterization of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) binding sites in C57BL/6 mouse brain: mutual effects of monoamine oxidase inhibitors and sigma ligands on MPTP and sigma binding sites.
Molecular pharmacology 1991;39(3):385-93.
1991: W L Hearn; D D Flynn; G W Hime; S Rose; J C Cofino; E Mantero-Atienza; Charles V Wetli; Deborah C Mash
Cocaethylene: a unique cocaine metabolite displays high affinity for the dopamine transporter.
Journal of neurochemistry 1991;56(2):698-701.
1991: Marek-Marsel Mesulam; Changiz Geula; R Cosgrove; Deborah C Mash; Stephen Brimijoin
Immunocytochemical demonstration of axonal and perikaryal acetylcholinesterase in human cerebral cortex.
Brain research 1991;539(2):233-8.
1990: Deborah C Mash; John Pablo; D D Flynn; S M N Efange; William J Weiner
Characterization and distribution of transferrin receptors in the rat brain.
Journal of neurochemistry 1990;55(6):1972-9.
1990: S M N Efange; H F Kung; Deborah C Mash; M Jabir; J Billings; John Pablo; Aloke Dutta; A Freshler
Pargyline-sensitive selective accumulation of a radiolabeled MPTP analog in the primate cerebral cortex and basal ganglia.
Synapse (New York, N.Y.) 1990;5(3):207-12.
1989: S M N Efange; Deborah C Mash; F Hefti; H F Kung; J Billings
Selective visualization of rodent locus ceruleus by a radiolabeled N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analog.
Journal of neurochemistry 1989;53(2):459-64.
1989: D D Flynn; Deborah C Mash
Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine.
The Journal of pharmacology and experimental therapeutics 1989;250(2):573-81.
1989: F Hefti; Deborah C Mash
Localization of nerve growth factor receptors in the normal human brain and in Alzheimer's disease.
Neurobiology of aging 1989;10(1):75-87.
1988: Deborah C Mash; W F White; Marek-Marsel Mesulam
Distribution of muscarinic receptor subtypes within architectonic subregions of the primate cerebral cortex.
The Journal of comparative neurology 1988;278(2):265-74.
1988: Elliott J Mufson; Deborah C Mash; Louis B Hersh
Neurofibrillary tangles in cholinergic pedunculopontine neurons in Alzheimer's disease.
Annals of neurology 1988;24(5):623-9.
1986: D D Flynn; Deborah C Mash
Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
Journal of neurochemistry 1986;47(6):1948-54.
1986: Deborah C Mash; L T Potter
Autoradiographic localization of M1 and M2 muscarine receptors in the rat brain.
Neuroscience 1986;19(2):551-64.
1986: F Hefti; Jukka Hartikka; A Salvatierra; William J Weiner; Deborah C Mash
Localization of nerve growth factor receptors in cholinergic neurons of the human basal forebrain.
Neuroscience letters 1986;69(1):37-41.
1986: Karam Soliman; Deborah C Mash; C A Walker
The effect of altered 5-hydroxytryptamine levels on beta-endorphin content in rat brain.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1986;182(2):187-93.
1986: Elliott J Mufson; T L Martin; Deborah C Mash; B H Wainer; Marek-Marsel Mesulam
Cholinergic projections from the parabigeminal nucleus (Ch8) to the superior colliculus in the mouse: a combined analysis of horseradish peroxidase transport and choline acetyltransferase immunohistochemistry.
Brain research 1986;370(1):144-8.
1985: Deborah C Mash; D D Flynn; L T Potter
Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.
Science (New York, N.Y.) 1985;228(4703):1115-7.
1985: Deborah C Mash; D D Flynn; L Kalinoski; L T Potter
Circadian variations in radioligand binding to muscarine receptors in rat brain dependent upon endogenous agonist occupation.
Brain research 1985;331(1):35-8.
1978: K J Berkley; Deborah C Mash
Somatic sensory projections to the pretectum in the cat.
Brain research 1978;158(2):445-9.